Preview

Cardiovascular Therapy and Prevention

Advanced search

Possibilities of a biobank for serological monitoring of infectious morbidity

https://doi.org/10.15829/1728-8800-2023-3693

Abstract

Currently, monitoring infectious morbidity, control and forecasting the epidemic process is a topical health problem.

Aim. To analyze the capabilities of the biobank for serological monitoring of infectious diseases using the Epstein- Barr virus (EBV), which is associated with infectious mononucleosis, as well as somatic pathology, including cancer.

Material and methods. Using the quantitative enzyme- linked immunosorbent assay for specific antibodies to various EBV proteins, we studied blood serum samples from healthy individuals (2010, 2016, 2019, 2020, 2021 and 2022) from the collection of the N. F. Gamaleya National Center of Epidemiology and Microbiology.

Results. For the first time, the intensity of EBV epidemic process among apparently healthy adult residents of the capital was assessed using samples of biological material and a biobank information database. At the time of examination, 0,8% of individuals were not infected with EBV, and 9,4% suffered reactivation of a chronic infection. There were no significant changes in detection rate of markers over the years.

Conclusion. Certified collections of blood sera can be effectively used to study population immunity, the prevalence of individual infections, population protection nationwide, etc.

About the Authors

O. A. Svitich
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation

Moscow



V. V. Zverev
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation

Moscow



T. V. Solomay
I.I. Mechnikov Research Institute of Vaccines and Sera
Russian Federation

Moscow



T. A. Semenenko
N.F. Gamaleya National Center of Epidemiology and Microbiology
Russian Federation

Moscow



A. V. Nozdracheva
N.F. Gamaleya National Center of Epidemiology and Microbiology
Russian Federation

Moscow



T. P. Gotvyanskaya
N.F. Gamaleya National Center of Epidemiology and Microbiology
Russian Federation

Moscow



References

1. Anisimov SV, Akhmerov TM, Balanovsky OP, et al. Biobanking. National Manual. Moscow: TRIUMPH Publishing House LLC, 2022. 308 p. (In Russ.) . ISBN: 978­5­93673­322­2.

2. Anisimov SV, Granstrem OK, Meshkov AN, et al. National association of biobanks and biobanking specialists: new community for promoting biobanking ideas and projects in Russia. Biopreserv Biobank. 2021;19(1):73­82. doi:10.1089/bio.2020.0049.

3. Semenenko TA, Anan’ina YV, Boev BV, et al. Banks of biological resources in the system of basic epidemiological and clinical studies. Annals of the Russian academy of medical sciences. 2011;10:59. (In Russ.)

4. Coates KM. Opportunities and challenges of a World Serum Bank. Lancet. 2017;389(10066):251­2. doi:10.1016/S0140­6736(17)30052­1.

5. Semenenko TA. The role of the blood serum bank in the biological safety system of the country. Bulletin of Roszdravnadzor. 2010; 3:55­8. (In Russ.)

6. Rogier EW, Giorgi E, Tetteh K, Sepúlveda N. Editorial: Current research on serological analyses of infectious diseases. Front Med (Lausanne). 2023;10:1154584. doi:10.3389/fmed.2023.1154584.

7. Semenenko TA, Akimkin VG. Seroepidemiology in the surveillance of vaccine­ preventable diseases. Journal of microbiology, epidemiology and immunobiology. 2018;95(2):87­94. (In Russ.) doi:10.36233/0372­9311­2018­2­87­94.

8. Metcalf CJ, Farrar J, Cutts FT, et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet. 2016;388(10045):728­30. doi:10.1016/S0140­6736(16)30164­7.

9. Nozdracheva AV, Semenenko TA. The effect of long­term storage of blood serum samples in a biobank for population­ based seroepidemiological studies. Cardiovascular Therapy and Prevention. 2022;21(11):3407. (In Russ.). doi:10.15829/1728­8800­2022­3407.

10. Pokrovskaya MS, Borisova AL, Metelskaya VA, et al. The role of biobanking in the organization of large­scale epidemiological studies. Cardiovascular Therapy and Prevention. 2021;20(5):2958. (In Russ.) doi:10.15829/1728­8800­2021­2958.

11. Semenenko TA, Lunin VG, Ginzburg AL. Blood serum bank as a component of the biological safety system. Journal of Microbiology, Epidemiology and Immunobiology. 2007;4:73­8. (In Russ.)

12. Annaratone L, De Palma G, Bonizzi G, et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch. 2021;479(2):233­46. doi:10.1007/S00428­021­03151­0.

13. Meshkov AN, Yartseva OYu, Borisova AL, et al. The concept of the national information platform of biobanks of the Russian Federation. Cardiovascular Therapy and Prevention. 2022;21(11):3417. (In Russ.) doi:10.15829/1728­8800­2022­3417.

14. Solomay TV, Semenenko TA, Karazhas NV, et al. Assessment of the risk of infection with herpesviruses during transfusion of donated blood and its components. Health risk analysis. 2020;2:136­42. (In Russ.) doi:10.21668/health.risk/2020.2.15.

15. Gotvyanskaya TP, Mukasheva EA, Nozdracheva AV, et al. Incidence and population immunity to influenza and ARVI in the context of the covid­19 pandemic. Sanitary Doctor. 2023;3:153­63. (In Russ.) doi:10.33920/med­08­2303­03.

16. Semenenko TA, Akimkin VG, Burtseva EI, et al. Characteristics of the Epidemic Situation Associated with Acute Respiratory Viral Infections in the Russian Federation during the Pandemic Spread of COVID­19. Epidemiology and Vaccinal Prevention. 2022;21(4):4­15. (In Russ.) doi:10.31631/20733046­2022­21­4­4­15.

17. Nozdracheva AV, Asatryan MN, Rybak LA, et al. Improvement of epidemiological diagnosis in the system of epidemiological surveillance of current infections by creating a database of the results of foci investigation. Sanitary Doctor. 2022;5:316­25. (In Russ.) doi:10.33920/med08­2205­01.

18. Solomay TV, Semenenko TA, Bloch AI. The prevalence of antibodies to the Epstein­ Barr virus in different age groups of the population of Europe and Asia: a systematic review and meta­analysis. Healthcare of the Russian Federation. 2021;65(3):276­86. (In Russ.) doi:10.47470/0044­197X­2021­65­3­276­286.

19. Nozdracheva AV, Semenenko TA, Asatryan MN, et al. Immunological susceptibility of the megalopolis population to measles at the stage of its elimination. Epidemiology and vaccination prevention. 2019;18(2):18­26. (In Russ.) doi:10.31631/2073­3046­2019­18­2­18­26.

20. Solomay TV, Semenenko TA. Viral hepatitis B, C and infectious mononucleosis: epidemiological similarities and differences. Problems of virology. 2020;65(1):27­34. (In Russ.) doi:10.36233/05074088­2020­65­1­27­34.

21. Solomay TV, Semenenko TA, Filatov NN, et al. The role of children and adults as a reservoir of pathogens during the seasonal rise in the incidence of upper respiratory tract infections. Childhood infections. 2020;19(3):5­11. (In Russ.) doi:10.22627/2072­81072020­19­3­5­11.

22. Shamsheva OV, Kharlamova FS, Egorova NYu, et al. The results of a long­term study of herpesvirus infection at the Department of Infectious Diseases in Children of the N. I. Pirogov RNIMU. Childhood infections. 2017;16(2):5­12. (In Russ.) doi:10.22627/2072­8107­2017­16­2­5­12.

23. Sivakova OV, Pokrovskaya MS, Efimova IA, et al. Quality control of blood serum and plasma samples for scientific research. Preventive medicine. 2019;22(5):91­7. (In Russ.) doi:10.17116/profmed20192205191.

24. Kozlova VA, Metelskaya VA, Pokrovskaya MS, et al. To study the stability of biochemical markers during continuous long­term storage of blood serum and with a single defrosting. Cardiovascular Therapy and Prevention. 2020;19(6):2736. (In Russ.) doi:10.15829/1728­8800­2020­2736.

25. Solomay TV, Semenenko TA. Epstein­ Barr viral infection is a global epidemiological problem. Problems of virology. 2022;67(4):265­77. (In Russ.) doi:10.36233/0507­4088­122.

26. Svitich OA, Filina AB, Davydova NV, et al. The role of factors of innate immunity in the process of tumor formation. Medical im munology. 2018;20(2):151­62. (In Russ.) doi:10.15789/1563­06252018­2­151­162.

27. Somiari SB, Somiari RI. The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers. Adv Exp Med Biol. 2015;864:11­27. doi:10.1007/978­3­319­20579­3_2.

28. Solomay TV, Semenenko AV, Nikitina GYu, et al. Predictive scenarios of the development of the epidemic process of infection caused by the Epstein­ Barr virus at the stage of the absence of specific prevention measures and their implementation. Epidemiology and infectious diseases. Current issues. 2023;13(1):60­9. (In Russ.) doi:10.18565/epidem.2023.13.1.60­9.

29. Coppola L, Cianflone A, Grimaldi AM, et al. Biobanking in health care: evolution and future directions. J Transl Med. 2019;17(1):172. doi:10.1186/s12967­019­1922­3.

30. Vaccines and vaccination: national guidelines. Ed.: V. V. Zverev, B. F. Semenov, R. M. Khaitov. M.: GEOTAR­Media. 2011. 880 p. (In Russ.) ISBN: 978­5­9704­2052­2.


Supplementary files

What is already known about the subject?

  • Biobanking technologies are the best practices in global healthcare and play an important role in the development of tools for diagnosing and treating somatic pathologies, studying the epidemiological and pathogenetic features of known and "new" infections.
  • Seroepidemiological studies, based on the col­lection and study of serum samples, provide the most reliable information about the population im­mune system.

What might this study add?

  • Studies of serum obtained from the biobank make it possible to retrospectively assess the intensity and changes of the epidemic process of Epstein-­Barr virus infection for its subsequent modeling, forecasting and developing a measures to reduce its burden.

Review

For citations:


Svitich O.A., Zverev V.V., Solomay T.V., Semenenko T.A., Nozdracheva A.V., Gotvyanskaya T.P. Possibilities of a biobank for serological monitoring of infectious morbidity. Cardiovascular Therapy and Prevention. 2023;22(11):3693. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3693

Views: 272


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)